Diabetes Mellitus Reduces the Function and Expression of ATP-dependent K⁺ Channels in Cardiac Mitochondria

Overview

Journal Life Sci

Publisher Elsevier

Specialties Biochemistry
Biology
Physiology

Date 2012 Dec 25

PMID 23261529

Citations 13

Authors

Ibra S Fancher

Gregory M Dick

John M Hollander

Affiliations

Soon will be listed here.

Abstract

Aim: Our goal was to determine the effects of type I diabetes mellitus on the function and expression of ATP-dependent K(+) channels in cardiac mitochondria (mitoKATP), composed of a pore-forming subunit (Kir6.1) and a diazoxide-sensitive sulphonylurea receptor (SUR1). We tested the hypothesis that diabetes reduces Kir6.1 and SUR1 expression as well as diazoxide-induced depolarization of mitochondrial membrane potential (ΔΨm).

Main Methods: Male FVB mice were made diabetic for 5weeks with multiple low dose injections of streptozotocin. Cardiac mitochondria were separated into two populations: subsarcolemmal mitochondria (SSM) and interfibrillar mitochondria (IFM). mitoKATP expression was determined via Western blot analysis of Kir6.1 and SUR1 proteins. mitoKATP function was determined by measuring ΔΨm with the potentiometric dye rhodamine 123.

Key Findings: Diabetes reduced Kir6.1 and SUR1 expression in IFM by over 40% (p<0.05 for both). Similarly, diabetes reduced Kir6.1 expression in SSM by approximately 40% (p<0.05); however, SUR1 expression was unaffected. Opening mitoKATP with diazoxide (100μM) depolarized control IFM ΔΨm by 80% of the valinomycin maximum; diabetic IFM depolarized only 30% (p<0.05). Diazoxide-induced depolarization was much less in SSM (20-30%) and unaffected by diabetes.

Significance: Our data indicate that diabetes reduces mitoKATP expression and function in IFM. These changes in mitoKATP may provide an opportunity to understand mechanisms leading to diabetic cardiomyopathy and loss of cardioprotective mechanisms in the diabetic heart.

Citing Articles

Loss of ATP-Sensitive Potassium Channel Expression and Function in the Nervous System Decreases Opioid Sensitivity in a High-Fat Diet-Fed Mouse Model of Diet-Induced Obesity.

Fisher C, Johnson K, Moore M, Sadrati A, Janecek J, Graham M Diabetes. 2024; 73(8):1244-1254.

PMID: 38776417 PMC: 11262047. DOI: 10.2337/db23-1030.

Loss of ATP-sensitive channel expression and function decreases opioid sensitivity in a mouse model of type 2 diabetes.

Fisher C, Johnson K, Moore M, Sadrati A, Janecek J, Graham M bioRxiv. 2023; .

PMID: 37732180 PMC: 10508758. DOI: 10.1101/2023.09.06.556526.

Effects of Naringin on Cardiomyocytes From a Rodent Model of Type 2 Diabetes.

Uryash A, Mijares A, Flores V, Adams J, Lopez J Front Pharmacol. 2021; 12:719268.

PMID: 34497520 PMC: 8419284. DOI: 10.3389/fphar.2021.719268.

Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway.

Wang J, Bai J, Duan P, Wang H, Li Y, Zhu Q J Cell Mol Med. 2021; 25(8):3935-3949.

PMID: 33547878 PMC: 8051713. DOI: 10.1111/jcmm.16346.

Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options.

Cieluch A, Uruska A, Zozulinska-Ziolkiewicz D Int J Mol Sci. 2020; 21(8).

PMID: 32325880 PMC: 7215501. DOI: 10.3390/ijms21082852.

References

Kehl F, Krolikowski J, Mraovic B, Pagel P, Warltier D, Kersten J . Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology. 2001; 96(1):183-8. DOI: 10.1097/00000542-200201000-00032. View

de Simone G, Devereux R, Chinali M, Lee E, Galloway J, Barac A . Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens. 2009; 28(2):353-60. PMC: 3005764. DOI: 10.1097/HJH.0b013e3283331169. View

Queliconi B, Wojtovich A, Nadtochiy S, Kowaltowski A, Brookes P . Redox regulation of the mitochondrial K(ATP) channel in cardioprotection. Biochim Biophys Acta. 2010; 1813(7):1309-15. PMC: 3109179. DOI: 10.1016/j.bbamcr.2010.11.005. View

Weinstein E, Benson D, Fry D . Subpopulations of human heart mitochondria. J Surg Res. 1986; 40(5):495-8. DOI: 10.1016/0022-4804(86)90221-0. View

Dabkowski E, Williamson C, Bukowski V, Chapman R, Leonard S, Peer C . Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations. Am J Physiol Heart Circ Physiol. 2008; 296(2):H359-69. PMC: 2643887. DOI: 10.1152/ajpheart.00467.2008. View

GARLID K, Paucek P, Yarov-Yarovoy V, Murray H, Darbenzio R, DAlonzo A . Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res. 1997; 81(6):1072-82. DOI: 10.1161/01.res.81.6.1072. View

Ardehali H, ORourke B . Mitochondrial K(ATP) channels in cell survival and death. J Mol Cell Cardiol. 2005; 39(1):7-16. PMC: 2692534. DOI: 10.1016/j.yjmcc.2004.12.003. View

Baseler W, Dabkowski E, Williamson C, Croston T, Thapa D, Powell M . Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction. Am J Physiol Regul Integr Comp Physiol. 2010; 300(2):R186-200. PMC: 3043804. DOI: 10.1152/ajpregu.00423.2010. View

Shen X, Zheng S, Thongboonkerd V, Xu M, Pierce Jr W, Klein J . Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab. 2004; 287(5):E896-905. DOI: 10.1152/ajpendo.00047.2004. View

10.

Ramanadham S, Young J, Tenner Jr T . Prevention of streptozotocin-induced alterations in the rat heart by 3-O-methyl glucose and insulin treatments. J Cardiovasc Pharmacol. 1987; 9(3):291-7. DOI: 10.1097/00005344-198703000-00005. View

11.

Hoppel C, Tandler B, Fujioka H, Riva A . Dynamic organization of mitochondria in human heart and in myocardial disease. Int J Biochem Cell Biol. 2009; 41(10):1949-56. PMC: 3221317. DOI: 10.1016/j.biocel.2009.05.004. View

12.

Holmuhamedov E, Wang L, Terzic A . ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J Physiol. 1999; 519 Pt 2:347-60. PMC: 2269505. DOI: 10.1111/j.1469-7793.1999.0347m.x. View

13.

Emaus R, Grunwald R, Lemasters J . Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties. Biochim Biophys Acta. 1986; 850(3):436-48. DOI: 10.1016/0005-2728(86)90112-x. View

14.

Liu Y, Ren G, ORourke B, Marban E, Seharaseyon J . Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. Mol Pharmacol. 2001; 59(2):225-30. View

15.

Kersten J, Montgomery M, Ghassemi T, Gross E, Toller W, Pagel P . Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol. 2001; 280(4):H1744-50. DOI: 10.1152/ajpheart.2001.280.4.H1744. View

16.

Aggarwal N, Pravdic D, McNally E, Bosnjak Z, Shi N, Makielski J . The mitochondrial bioenergetic phenotype for protection from cardiac ischemia in SUR2 mutant mice. Am J Physiol Heart Circ Physiol. 2010; 299(6):H1884-90. PMC: 3006279. DOI: 10.1152/ajpheart.00363.2010. View

17.

Leiter E . Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus. Proc Natl Acad Sci U S A. 1982; 79(2):630-4. PMC: 345800. DOI: 10.1073/pnas.79.2.630. View

18.

Baracca A, Sgarbi G, Solaini G, Lenaz G . Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. Biochim Biophys Acta. 2003; 1606(1-3):137-46. DOI: 10.1016/s0005-2728(03)00110-5. View

19.

Ardehali H, Chen Z, Ko Y, Mejia-Alvarez R, Marban E . Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K+ channel activity. Proc Natl Acad Sci U S A. 2004; 101(32):11880-5. PMC: 511068. DOI: 10.1073/pnas.0401703101. View

20.

Foster D, Rucker J, Marban E . Is Kir6.1 a subunit of mitoK(ATP)?. Biochem Biophys Res Commun. 2007; 366(3):649-56. PMC: 2276631. DOI: 10.1016/j.bbrc.2007.11.154. View